Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 1D-27 (IGKV1D-27) refers to a variable (V) region gene segment located in the distal segment of the immunoglobulin kappa light chain locus on chromosome 2p11.2. The gene segment encodes part of the variable domain of the kappa light chains in immunoglobulins, enabling B cells to generate diverse antigen-binding sites through V-J gene rearrangement and somatic hypermutation. IGKV1D-27 is not a receptor, enzyme, or classical therapeutic target; it is part of the genetic template for antibodies essential in adaptive immune response[2][3][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin kappa variable 1D-27 (IGKV1D-27).